Adenovirus-mediated transfer and expression of beta-Gal in injured hippocampus after traumatic brain injury in mice

Citation
Pm. Kochanek et al., Adenovirus-mediated transfer and expression of beta-Gal in injured hippocampus after traumatic brain injury in mice, J NEUROTRAU, 18(1), 2001, pp. 73-82
Citations number
49
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROTRAUMA
ISSN journal
08977151 → ACNP
Volume
18
Issue
1
Year of publication
2001
Pages
73 - 82
Database
ISI
SICI code
0897-7151(200101)18:1<73:ATAEOB>2.0.ZU;2-X
Abstract
In models of focal cerebral ischemia, adenoviral gene transfer is often att enuated or delayed versus naive. After controlled cortical impact (CCI)-ind uced traumatic brain injury in mice, CA1 and CA3 hippocampus exhibit delaye d neuronal death by 3 days, with subsequent near complete loss of hippocamp us by 21 days. We hypothesized that adenoviral-mediated expression of the r eporter gene beta -Galactosidase (beta -Gal) in hippocampus would be attenu ated after CCI in mice. C57BL6 mice (n = 16) were subjected to either CCI t o left parietal cortex or sham (burr hole). Adenovirus carrying the beta -G al gene (AdlacZ; 1 x 10(9) plaque-forming units [pfu]/mL) was then injected into left dorsal hippocampus. At 24 or 72 h, beta -Gal expression was quan tified (mU/mg protein). Separate mice (n = 10) were used to study beta -Gal spatial distribution in brain sections. beta -Gal expression in left hippo campus was similar in shams at 24 h (48.4 +/- 4.1) versus 72 h (68.8 +/- 8. 8, not significant). CCI did not reduce beta -Gal expression in left hippoc ampus (68.8 +/- 8.8 versus 88.1 +/- 7.0 at 72 h, sham versus CCI, not signi ficant). In contrast, CCI reduced beta -Gal expression in right (contralate ral) hippocampus versus sham (p < 0.05 at both 24 and 72 h). <beta>-Gal was seen in many cell types in ipsilateral hippocampus, including CA3 neurons. Despite eventual loss of ipsilateral hippocampus, adenovirus-mediated gene transfer was surprisingly robust early after CCI providing an opportunity to test novel genes targeting delayed hippocampal neuronal death.